H Menzel

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Michael Neuenhahn, Julia Albrecht, Marcus Odendahl et al. · Leukemia · 2017 · 161 citations · Full text

Medicine, Immunology, Infectious Diseases +12

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 154 citations · Full text

Medicine, Hematology, Immunology +17

Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients

Dieter Hoffmann, Martin Hutzenthaler, Judith Seebach et al. · Infection Genetics and Evolution · 2012 · 28 citations

Life Sciences, Infectious Diseases, Microbiology +14

Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models

Horst Lindhofer, H Menzel, W. Günther et al. · Blood · 1996 · 26 citations · Full text

Life Sciences, Immunology, Oncology +13

Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.

Hans‐Joachim Stemmler, Christoph Salat, Horst Lindhofer et al. · PubMed · 2005 · 18 citations

Medicine, Oncology, Pharmacology +17